Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN

162Citations
Citations of this article
358Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pancreatic cancer is still a dismal disease. The high mortality rate is mainly caused by the lack of highly sensitive and specific diagnostic tools, and most of the patients are diagnosed in an advanced and incurable stage. Knowledge about precursor lesions for pancreatic cancer has grown significantly over the last decade, and nowadays we know that mainly three lesions (PanIN, and IPMN, MCN) are responsible for the development of pancreatic cancer. The early detection of these lesions is still challenging but provides the chance to cure patients before they might get an invasive pancreatic carcinoma. This paper focuses on PanIN, IPMN, and MCN lesions and reviews the current level of knowledge and clinical measures. © 2014 M. Distler et al.

Cite

CITATION STYLE

APA

Distler, M., Aust, D., Weitz, J., Pilarsky, C., & Grützmann, R. (2014). Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. BioMed Research International. Hindawi Publishing Corporation. https://doi.org/10.1155/2014/474905

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free